$41.09 -0.16 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Aug. 31, 2015 | 11:20 AM

Partner Headlines

  1. Five Prime Therapeutics Announces Oral Presentation of Initial Data From Ongoing Phase 1b Trial of FP-1039/GSK3052230 in Squamous Non Small Cell Lung Cancer and Mesothelioma at World Conference on Lung Cancer

    Benzinga | Aug. 24, 2015 | 04:20AM EST
  2. Dodge & Cox Acquires Stake in Priceline

    GuruFocus | Aug. 21, 2015 | 18:31PM EST
  3. AptarGroup: The Leader in Dispensing Innovation

    GuruFocus | Aug. 21, 2015 | 15:31PM EST
  4. US Stock Futures Slide Ahead Of Deere, Foot Locker Earnings

    Benzinga | Aug. 21, 2015 | 07:06AM EST
  5. Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop Treatments for MS, Other Autoimmune Indications

    Benzinga | Aug. 21, 2015 | 04:34AM EST
  6. GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma

    GuruFocus | Aug. 7, 2015 | 00:04AM EST
  7. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  8. Week Ahead: FOMC Meeting, GDP and More Earnings

    FoxBusiness | Jul. 24, 2015 | 16:28PM EST
  9. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD | Jul. 21, 2015 | 13:15PM EST
  10. It's Not Too Late To Buy Gilead Sciences

    GuruFocus | Jul. 17, 2015 | 12:01PM EST
  11. Benzinga's Volume Movers

    Benzinga | Jul. 9, 2015 | 10:32AM EST
  12. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  13. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  14. Biotech IPOs Steam Ahead Despite Fears Of Overload

    IBD | Jun. 23, 2015 | 08:02AM EST
  15. 5 NYSE Healthcare Stocks With The Highest ROE

    Benzinga | Jun. 22, 2015 | 09:29AM EST
  16. Jim Cramer Advises His Viewers On GlaxoSmithKline, American International Group, Caesars And Caesars Acquisition

    Benzinga | Jun. 18, 2015 | 07:12AM EST
  17. Billionaire George Soros Ups Two Stakes in First Quarter

    GuruFocus | Jun. 16, 2015 | 13:01PM EST
  18. Weekly 3-Year Low Highlights: GSK, TRP, NOV, CHK

    GuruFocus | Jun. 15, 2015 | 12:01PM EST
  19. Guru Stocks at 52-Week Lows: XOM, WMT, PG, CVX, GSK

    GuruFocus | Jun. 14, 2015 | 19:07PM EST
  20. Axovant IPO Best In 20 Years

    IBD | Jun. 11, 2015 | 18:56PM EST
  21. Axovant Sciences Sets 20-Year Record For Biotech IPOs

    IBD | Jun. 11, 2015 | 16:58PM EST
  22. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD | Jun. 11, 2015 | 12:58PM EST
  23. Will GlaxoSmithKline Cut Its 6% Dividend?

    GuruFocus | Jun. 3, 2015 | 15:32PM EST
  24. Perrigo buys Glaxo OTC drugs

    IBD | Jun. 2, 2015 | 18:40PM EST
  25. Will Perrigo's Glaxo Buy Make It Too Pricey?

    IBD | Jun. 2, 2015 | 13:08PM EST
  26. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  27. Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer

    GuruFocus | May. 22, 2015 | 18:21PM EST
  28. 9 International Dividend Dogs With Upside Potential

    GuruFocus | May. 22, 2015 | 16:48PM EST
  29. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  30. Tweedy Browne's Stocks With High Growing Yield

    GuruFocus | May. 11, 2015 | 18:39PM EST
  31. Kahn Brothers Ups Investment in 4 Stocks

    GuruFocus | May. 8, 2015 | 14:39PM EST
  32. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  33. IPO Stock Watch: Adaptimmune Upsizes But Stock Slips

    IBD | May. 6, 2015 | 17:20PM EST
  34. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  35. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD | May. 4, 2015 | 13:03PM EST
  36. GlaxoSmithKline

    IBD | Apr. 27, 2015 | 18:45PM EST
  37. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  38. Taking a Closer Look at GlaxoSmithKline

    GuruFocus | Apr. 22, 2015 | 12:37PM EST
  39. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  40. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  41. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  42. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  43. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  44. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  45. Stocks Edge Higher Friday; Glaxo, Taiwan Semi Muscle Up

    IBD | Feb. 13, 2015 | 10:41AM EST
  46. Bestinfond's Top 5 New Buys During Q4

    GuruFocus | Feb. 3, 2015 | 16:15PM EST
  47. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  48. Can GlaxoSmithKline Continue Striving in the Face of World Challenges?

    GuruFocus | Jan. 30, 2015 | 11:17AM EST
  49. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD

    Benzinga | Jan. 26, 2015 | 09:21AM EST
  50. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!